Display options
Cite
McCarty MF, DiNicolantonio JJ. Acarbose, lente carbohydrate, and prebiotics promote metabolic health and longevity by stimulating intestinal production of GLP-1. Open Heart. 2015;2(1):e000205doi: 10.1136/openhrt-2014-000205.
McCarty, M. F., & DiNicolantonio, J. J. (2015). Acarbose, lente carbohydrate, and prebiotics promote metabolic health and longevity by stimulating intestinal production of GLP-1. Open heart, 2(1), e000205. https://doi.org/10.1136/openhrt-2014-000205
McCarty, Mark F, and DiNicolantonio, James J. "Acarbose, lente carbohydrate, and prebiotics promote metabolic health and longevity by stimulating intestinal production of GLP-1." Open heart vol. 2,1 (2015): e000205. doi: https://doi.org/10.1136/openhrt-2014-000205
McCarty MF, DiNicolantonio JJ. Acarbose, lente carbohydrate, and prebiotics promote metabolic health and longevity by stimulating intestinal production of GLP-1. Open Heart. 2015 Jan 29;2(1):e000205. doi: 10.1136/openhrt-2014-000205. eCollection 2015. PMID: 25685364; PMCID: PMC4316590.
Copy Download .nbib Format: NLM
Share it on

Open Heart. 2015 Jan 29;2(1):e000205. doi: 10.1136/openhrt-2014-000205. eCollection 2015.

Acarbose, lente carbohydrate, and prebiotics promote metabolic health and longevity by stimulating intestinal production of GLP-1.

Open heart

Mark F McCarty, James J DiNicolantonio

Affiliations

  1. Catalytic Longevity , Encinitas, California , USA.
  2. Mid America Heart Institute, St. Luke's Hospital , Kansas City, Missouri , USA ; Wegmans Pharmacy , Ithaca, New York , USA.

PMID: 25685364 PMCID: PMC4316590 DOI: 10.1136/openhrt-2014-000205

Abstract

The α-glucosidase inhibitor acarbose, which slows carbohydrate digestion and blunts postprandial rises in plasma glucose, has long been used to treat patients with type 2 diabetes or glucose intolerance. Like metformin, acarbose tends to aid weight control, postpone onset of diabetes and decrease risk for cardiovascular events. Acarbose treatment can favourably affect blood pressure, serum lipids, platelet aggregation, progression of carotid intima-media thickness and postprandial endothelial dysfunction. In mice, lifetime acarbose feeding can increase median and maximal lifespan-an effect associated with increased plasma levels of fibroblast growth factor 21 (FGF21) and decreased levels of insulin-like growth factor-I (IGF-I). There is growing reason to suspect that an upregulation of fasting and postprandial production of glucagon-like peptide-1 (GLP-1)-stemming from increased delivery of carbohydrate to L cells in the distal intestinal tract-is largely responsible for the versatile health protection conferred by acarbose. Indeed, GLP-1 exerts protective effects on vascular endothelium, the liver, the heart, pancreatic β cells, and the brain which can rationalise many of the benefits reported with acarbose. And GLP-1 may act on the liver to modulate its production of FGF21 and IGF-I, thereby promoting longevity. The benefits of acarbose are likely mimicked by diets featuring slowly-digested 'lente' carbohydrate, and by certain nutraceuticals which can slow carbohydrate absorption. Prebiotics that promote colonic generation of short-chain fatty acids represent an alternative strategy for boosting intestinal GLP-1 production. The health benefits of all these measures presumably would be potentiated by concurrent use of dipeptidyl peptidase 4 inhibitors, which slow the proteolysis of GLP-1 in the blood.

References

  1. Cardiovasc Hematol Agents Med Chem. 2007 Jan;5(1):79-90 - PubMed
  2. J Am Coll Nutr. 2009 Jun;28(3):266-76 - PubMed
  3. J Am Coll Nutr. 2003 Feb;22(1):36-42 - PubMed
  4. Elife. 2012 Oct 15;1:e00065 - PubMed
  5. Diabetes Care. 2005 Jan;28(1):154-63 - PubMed
  6. Diabet Med. 2008 Apr;25(4):435-41 - PubMed
  7. Diabetes. 2003 Nov;52(11):2795-804 - PubMed
  8. Biochem Biophys Res Commun. 2007 Aug 24;360(2):437-40 - PubMed
  9. Clin Sci (Lond). 2014 Jan 1;126(1):19-29 - PubMed
  10. Am J Med. 2002 Dec 30;113 Suppl 9B:30S-37S - PubMed
  11. Biochim Biophys Acta. 1998 Oct 14;1388(1):10-20 - PubMed
  12. Clin Ther. 2010 Aug;32(9):1610-7 - PubMed
  13. Cardiovasc Diabetol. 2014 Apr 16;13:81 - PubMed
  14. Diabetologia. 2011 May;54(5):1098-108 - PubMed
  15. Circ Cardiovasc Interv. 2011 Jun;4(3):266-72 - PubMed
  16. Diabet Med. 2004 Mar;21(3):208-13 - PubMed
  17. Cell Metab. 2008 Aug;8(2):169-74 - PubMed
  18. Neuropharmacology. 2014 Nov;86:241-58 - PubMed
  19. Tohoku J Exp Med. 1983 Dec;141 Suppl:677-81 - PubMed
  20. Diabetes Res Clin Pract. 2003 Sep;61(3):183-90 - PubMed
  21. Am J Health Syst Pharm. 2013 Dec 1;70(23):2097-103 - PubMed
  22. Metab Syndr Relat Disord. 2012 Dec;10(6):387-90 - PubMed
  23. Diabet Med. 1998 Jun;15(6):485-91 - PubMed
  24. Islets. 2012 Nov-Dec;4(6):359-65 - PubMed
  25. Lancet. 2002 Jun 15;359(9323):2072-7 - PubMed
  26. Am J Physiol Gastrointest Liver Physiol. 2001 Sep;281(3):G752-63 - PubMed
  27. Diabetologia. 2004 May;47(5):806-15 - PubMed
  28. J Med Assoc Thai. 2007 Oct;90(10 ):2150-7 - PubMed
  29. Diabetes Metab J. 2011 Oct;35(5):444-50 - PubMed
  30. Stroke. 2004 May;35(5):1073-8 - PubMed
  31. Neuropharmacology. 2014 Jan;76 Pt A:57-67 - PubMed
  32. Diabetes Care. 1999 Jun;22(6):913-9 - PubMed
  33. Ann Pharmacother. 2012 Dec;46(12):1700-6 - PubMed
  34. J Cardiovasc Pharmacol. 2009 Jul;54(1):25-30 - PubMed
  35. Rev Endocr Metab Disord. 2014 Sep;15(3):189-96 - PubMed
  36. JAMA. 2003 Jul 23;290(4):486-94 - PubMed
  37. Diabetes Metab Res Rev. 2013 Oct;29(7):582-91 - PubMed
  38. Atherosclerosis. 2005 Dec;183(2):259-67 - PubMed
  39. Metabolism. 2008 Sep;57(9):1299-306 - PubMed
  40. Mol Nutr Food Res. 2011 Oct;55(10 ):1499-508 - PubMed
  41. Scand J Gastroenterol. 1995 Sep;30(9):892-6 - PubMed
  42. Diabetes Obes Metab. 2002 Sep;4(5):329-35 - PubMed
  43. J Clin Endocrinol Metab. 2012 Dec;97(12):4701-8 - PubMed
  44. Liver Int. 2011 Oct;31(9):1285-97 - PubMed
  45. Hepatol Res. 2015 Mar;45(3):269-78 - PubMed
  46. J Cereb Blood Flow Metab. 2011 Aug;31(8):1696-705 - PubMed
  47. Diabetologia. 2011 May;54(5):1219-26 - PubMed
  48. Cell Metab. 2009 Apr;9(4):327-38 - PubMed
  49. PLoS One. 2014 May 16;9(5):e97554 - PubMed
  50. Chin Med J (Engl). 2008 Oct 20;121(20):2054-9 - PubMed
  51. Metabolism. 2011 Aug;60(8):1081-9 - PubMed
  52. J Res Med Sci. 2013 May;18(5):391-4 - PubMed
  53. Am J Physiol Regul Integr Comp Physiol. 2004 Dec;287(6):R1387-93 - PubMed
  54. Endocrinology. 2012 Feb;153(2):750-8 - PubMed
  55. Diabetes Metab J. 2012 Aug;36(4):262-7 - PubMed
  56. Nat Med. 2003 Sep;9(9):1173-9 - PubMed
  57. Rev Endocr Metab Disord. 2014 Sep;15(3):233-42 - PubMed
  58. Am J Physiol Gastrointest Liver Physiol. 2012 Jan 15;302(2):G225-35 - PubMed
  59. Lancet. 1979 May 5;1(8123):987-8 - PubMed
  60. Int J Med Sci. 2007 Jan 24;4(1):45-52 - PubMed
  61. J Biol Chem. 2013 Aug 30;288(35):25088-97 - PubMed
  62. Nutr Metab Cardiovasc Dis. 2007 May;17(4):257-67 - PubMed
  63. Cardiovasc Diabetol. 2013 May 04;12 :73 - PubMed
  64. J Alzheimers Dis. 2013;37(3):623-35 - PubMed
  65. Diabetes Care. 2011 May;34 Suppl 2:S120-7 - PubMed
  66. PLoS One. 2012;7(11):e48392 - PubMed
  67. Clin Cardiol. 2009 May;32(5):236-43 - PubMed
  68. Am J Clin Nutr. 2009 Nov;90(5):1236-43 - PubMed
  69. Aging Cell. 2014 Apr;13(2):273-82 - PubMed
  70. Curr Diab Rep. 2007 Oct;7(5):333-9 - PubMed
  71. Diabetes. 2011 Nov;60(11):2775-86 - PubMed
  72. Cardiol J. 2013;20(1):29-33 - PubMed
  73. Diabetes. 2012 Feb;61(2):364-71 - PubMed
  74. Diabetologia. 2010 Oct;53(10):2256-63 - PubMed
  75. Med Hypotheses. 2005;65(2):377-9 - PubMed
  76. Endocrinology. 2005 Sep;146(9):3718-23 - PubMed
  77. Diabetes Care. 1988 Feb;11(2):149-59 - PubMed
  78. Cardiovasc Drugs Ther. 2005 Jan;19(1):9-11 - PubMed
  79. Mol Nutr Food Res. 2013 Feb;57(2):347-59 - PubMed
  80. J Hepatol. 2011 Jun;54(6):1214-23 - PubMed
  81. Rejuvenation Res. 2012 Dec;15(6):624-8 - PubMed
  82. J Endocrinol. 2013 Jan 18;216(2):135-43 - PubMed
  83. PLoS One. 2012;7(12):e50117 - PubMed
  84. J Gerontol A Biol Sci Med Sci. 2011 Aug;66(8):917-24 - PubMed
  85. Biomed Res Int. 2014;2014:751930 - PubMed
  86. Peptides. 2013 Jan;39:71-9 - PubMed
  87. JAMA. 2006 Apr 12;295(14):1681-7 - PubMed
  88. Diabetes. 2008 May;57(5):1349-54 - PubMed
  89. Acta Pharmacol Sin. 2012 Jan;33(1):75-81 - PubMed
  90. Am Heart J. 2014 Jul;168(1):23-9.e2 - PubMed
  91. Diab Vasc Dis Res. 2011 Apr;8(2):117-24 - PubMed
  92. J Thromb Haemost. 2010 Apr;8(4):828-37 - PubMed
  93. J Diabetes Investig. 2011 Jun 5;2(3):200-3 - PubMed
  94. Eur J Clin Nutr. 1995 Oct;49 Suppl 3:S190-7 - PubMed
  95. Nutr J. 2009 Oct 28;8:52 - PubMed
  96. Am J Physiol Gastrointest Liver Physiol. 2012 Apr 15;302(8):G762-72 - PubMed
  97. CNS Drugs. 2012 Oct 1;26(10):871-82 - PubMed
  98. Gastroenterology. 2014 Feb;146(2):539-49.e7 - PubMed
  99. Cardiovasc Drugs Ther. 2008 Jun;22(3):225-31 - PubMed
  100. Nutr J. 2011 Mar 17;10:24 - PubMed
  101. Br J Pharmacol. 2010 Feb 1;159(3):495-501 - PubMed
  102. Braz J Med Biol Res. 2002 Aug;35(8):877-84 - PubMed
  103. Eur J Clin Invest. 2005 Sep;35(9):551-7 - PubMed
  104. Cell Metab. 2008 Jul;8(1):77-83 - PubMed
  105. J Physiol. 2005 Dec 15;569(Pt 3):761-72 - PubMed
  106. Hepatology. 2006 Jan;43(1):173-81 - PubMed
  107. Diabetes Care. 1982 Nov-Dec;5(6):634-41 - PubMed
  108. Horm Metab Res. 1983 Jan;15(1):1-3 - PubMed
  109. Eur Heart J. 2004 Jan;25(1):10-6 - PubMed
  110. Clin Ther. 2013 Jun;35(6):880-99 - PubMed
  111. Naturwissenschaften. 1977 Oct;64(10):536-7 - PubMed

Publication Types